Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-019502

Chief Executive Officer bought 4,300 shares at $3.49 ($15,007)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-03-17 Purchase : show line 1 in the form +4,300 $3.49 $15,007 71,090 D
Open-market purchases · 4,300 sh · avg $3.49 · $15,007
Loading xslF345X03/doc4.xml…